Gland Pharma Limited IPO

Gland Pharma Limited is listed in the MAINBOARD segment with a price band of ₹1,490 to ₹1,500. The figures below are as reported by the exchanges and public sources.

Gland Pharma Limited IPO — key facts

• The Gland Pharma Limited IPO price band is ₹1,490 to ₹1,500 per share.
• As of 5 September 2026, the Gland Pharma Limited IPO subscription status is 2.06x overall.
• The issue is open from 09-NOV-2020 to 11-NOV-2020.
• Gland Pharma Limited listed on 20-NOV-2020.
• Gland Pharma Limited listed at ₹1,820.45. The listing gain was 21.4% against the upper end of the issue price band.

Gland Pharma Limited IPO details

Status

Listed

Segment

MAINBOARD

Sector

Pharmaceuticals

Price band

₹1,490 – ₹1,500

Issue size

₹6479.55 Cr

Fresh issue

₹1250 Cr

Offer for sale

₹5229.55 Cr

Opens

09-NOV-2020

Closes

11-NOV-2020

Listing

20-NOV-2020

Total subscription

2.06x

Retail

0.24x

QIB

6.40x

NII

0.51x

Lead managers

Citigroup Global (left lead)

Listing price

₹1,820.45

Listing day change

+21.4%

Other Pharmaceuticals IPOs

• Symbiotec Pharmalab Limited +10.9% on listing
• ABH Healthcare Limited -7.8% on listing
• Bio Medica Laboratories Limited -16.7% on listing
• Goldline Pharmaceutical Ltd. +32.0% on listing
• Sai Parenteral's Limited +3.7% on listing
• Speciality Medicines Ltd. +1.5% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.